Shenzhen Salubris Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd., explained in plain language.
-
New Cholesterol-Lowering shot shows promise in major trial
Disease control CompletedThis study tested a new injectable medicine (SAL003) added to standard statin therapy in 720 adults with high cholesterol. The goal was to see if it safely lowers 'bad' LDL cholesterol more than a placebo. Participants had high cholesterol despite taking statins, and the treatmen…
Phase: PHASE3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 07:59 UTC
-
New shot could help lower stubborn high cholesterol
Disease control CompletedThis study tested a new injectable medicine called SAL003, given together with the common cholesterol pill atorvastatin, in 214 adults with high cholesterol or mixed dyslipidemia. The goal was to see if the combination could safely lower bad LDL cholesterol more than atorvastatin…
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New cholesterol drug shows promise in major trial
Disease control CompletedThis study tested a new medicine called SAL003 in 618 adults with high cholesterol. Participants received either the drug or a placebo every 4 weeks for 12 weeks. The goal was to see if SAL003 could safely lower bad cholesterol (LDL-C) more than placebo. After 12 weeks, all parti…
Phase: PHASE3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:39 UTC